Company
The Future Belongs To Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) For Risk-Tolerant Investors
During the last session, Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB)’s traded shares were 1.2 million, with the beta value of the company hitting 0.60. At the
